Nebracetam is an investigational drug of the racetam family that is a M1 acetylcholine receptor agonist in rats. Based on a human leukemic T cell experiment in 1991, it is believed to act as an agonist for human M1-muscarinic receptors. It is also believed to act as a nootropic, like many other racetam drugs. A chemoenzymatic method of synthesis was reported in 2008. , human trials have not yet been conducted.
Nebracetam is an investigational drug of the racetam family that is a M1 acetylcholine receptor agonist in rats. Based on a human leukemic T cell experiment in 1991, it is believed to act as an agonist for human M1-muscarinic receptors. It is also believed to act as a nootropic, like many other racetam drugs. A chemoenzymatic method of synthesis was reported in 2008. , human trials have not yet been conducted.
== See also == Piracetam Aniracetam Racetam
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).